VacZine Analytics Request the database
Sample preview

Who is developing which vaccines, and how far have they got?

Explore the verified pipelines of the large vaccine developers. Compare companies at a glance, then filter every active programme by phase, pathogen and segment. The licensed database covers more than 2,000 industry trials and the full developer landscape (VAMV084).

Part 1 | The landscape

Trial activity against live programmes

Each bubble is a large developer. Trial count measures activity since 2014; verified programmes show what is still active today. Select a bubble to see that company's pipeline below.

Programmes verified against company pipeline disclosures and trial registries, October 2026. Licensed and filed products are excluded from the bubble chart.

Bubble size: novel-segment programmes

Bubble chart of large vaccine developers: industry clinical trials since 2014 on the horizontal axis, verified active programmes on the vertical axis.

Industry-sponsored Phase 1 to 4 interventional trials, start dates 1 January 2014 to 22 October 2026. J&J and Takeda show trial history but no verified active programmes.

0verified active programmesacross 8 large developers
0in novel segmentspathogens without a licensed vaccine market
0in Phase 3the next likely approvals
0new since May 2026picked up in the October refresh

Part 2 | The pipeline

Every verified programme, by phase

Filter by developer, segment or pathogen. Drag the phase scrubber to narrow the stages shown, or play the tracker to see how the pipeline we follow has grown. Select a programme for its profile.

Developer
Phase range
Programmes tracked up to

Want the full pipeline database?

The licensed workbook includes more than 2,000 industry trials, small and medium developers, preclinical programmes, mRNA platform analysis and the October 2026 change log, with a briefing call.

Request pricing and a briefing